Targeted treatments plus engineered immune cells may slow early spread of triple‑negative breast cancer, study reveals

A new study has revealed a promising new approach to curb the spread of triple-negative breast cancer, one of the most aggressive and difficult-to-treat forms of the disease. Published recently in Cancer Letters, Gabriel Duda, Ph.D., scientific…

Continue Reading

News Source: medicalxpress.com